Fortis Group Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 1815183 WESTWOOD, NJ

Position in MRK

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$605,877

+$38,710 QoQ

Shares Held

4,715

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#2,533

of 3,766 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. MRK ranks #4 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,471	$4,163,221
2	NVO	Novo Nordisk A S	72,916	$3,495,593
3	PFE	Pfizer Inc	62,653	$1,508,683
4	MRK	Merck & Co., Inc. This page	4,715	$605,877
5	AMGN	Amgen Inc	559	$202,424
6	JNJ	Johnson & Johnson	718	$182,350
7	GILD	Gilead Sciences, Inc.	246	$31,079
8	BMY	Bristol Myers Squibb Co	500	$28,810

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$605,877	4,715	0.0%	Shares	Sole	2026-07-24
2026-03-31	$567,167	4,715	+0.1%	Shares	Sole	2026-05-08
2025-12-31	$495,984	4,712	+0.1%	Shares	Sole	2026-02-06
2025-09-30	$395,225	4,709	-3.6%	Shares	Sole	2025-11-07
2025-06-30	$386,617	4,884	+0.3%	Shares	Sole	2025-08-08
2025-03-31	$436,861	4,867	-0.4%	Shares	Sole	2025-05-02
2024-12-31	$486,158	4,887	-0.5%	Shares	Sole	2025-01-31
2024-09-30	$557,578	4,910	-0.3%	Shares	Sole	2024-10-21
2024-06-30	$609,466	4,923	-2.6%	Shares	Sole	2024-07-30
2024-03-31	$667,138	5,056	-1.3%	Shares	Sole	2024-04-30
2023-12-31	$558,508	5,123	+0.6%	Shares	Sole	2024-03-04
2023-09-30	$524,118	5,091	+0.6%	Shares	Sole	2023-12-01
2023-06-30	$583,988	5,061	0.0%	Shares	Sole	2023-07-18
2023-03-31	$538,439	5,061	-28.6%	Shares	Sole	2023-05-26
2020-09-30	$587,701	7,085	—	Shares	Sole	2020-11-17
No filing history on record for this holder in this stock.